125 related articles for article (PubMed ID: 36697267)
1. Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodules.
Heinze C; Damm R; Othmer M; Thormann M; Surov A; Hass P; Seidesticker R; Seidensticker M; Ricke J; Powerski M; Pech M; Omari J
Brachytherapy; 2023; 22(2):231-241. PubMed ID: 36697267
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma.
Karim H; Thormann M; Omari J; Surov A; Schinner R; Seidensticker R; Ingenerf M; Ricke J; Schmid-Tannwald C
Acta Radiol; 2024 Jan; 65(1):14-22. PubMed ID: 36843430
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas.
Omari J; Heinze C; Wilck A; Hass P; Seidensticker M; Seidensticker R; Mohnike K; Ricke J; Pech M; Powerski M
Eur J Radiol; 2019 Mar; 112():22-27. PubMed ID: 30777214
[TBL] [Abstract][Full Text] [Related]
5. Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma.
Mohnike K; Wieners G; Pech M; Seidensticker M; Rühl R; Lopez-Haenninen E; Ricke J
Dig Dis; 2009; 27(2):170-4. PubMed ID: 19546556
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
7. Local ablation of hepatocellular carcinoma by interstitial brachytherapy: prediction of outcome by diffusion-weighted imaging.
Thormann M; Surov A; Pech M; March C; Hass P; Damm R; Omari J
Acta Radiol; 2023 Apr; 64(4):1331-1340. PubMed ID: 36262039
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of
Xiang Z; Bai M; Li G; Zou B; Zhong Z; Gao F; Wu C; Huang M; Zhang F
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1907-1916. PubMed ID: 31161374
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy.
Omari J; Drewes R; Matthias M; Mohnike K; Seidensticker M; Seidensticker R; Streitparth T; Ricke J; Powerski M; Pech M
Brachytherapy; 2019; 18(1):63-70. PubMed ID: 30385116
[TBL] [Abstract][Full Text] [Related]
10. CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization?
Denecke T; Stelter L; Schnapauff D; Steffen I; Sinn B; Schott E; Seidensticker R; Puhl G; Gebauer B; Hänninen EL; Wust P; Neuhaus P; Seehofer D
Eur Radiol; 2015 Sep; 25(9):2608-16. PubMed ID: 25735513
[TBL] [Abstract][Full Text] [Related]
11. Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma.
Omari J; Heinze C; Wilck A; Hass P; Seidensticker M; Damm R; Fischbach K; Ricke J; Pech M; Powerski M
J Contemp Brachytherapy; 2018 Oct; 10(5):439-445. PubMed ID: 30479621
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma.
Song Z; Ye J; Wang Y; Li Y; Wang W
J Cancer Res Ther; 2019; 15(7):1553-1560. PubMed ID: 31939437
[TBL] [Abstract][Full Text] [Related]
13. Local tumor control of thoracoabdominal wall seeding tumor from hepatocellular carcinoma with ultrasound-guided interventional treatment: A summarized study.
An C; Li X; Liang P; Yu J; Cheng Z; Han Z; Mu M
J Cancer Res Ther; 2019; 15(2):404-414. PubMed ID: 30964119
[TBL] [Abstract][Full Text] [Related]
14. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
[TBL] [Abstract][Full Text] [Related]
15. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
[TBL] [Abstract][Full Text] [Related]
16. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
17. Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M; Link H; Hirner-Eppeneder H; Alunni-Fabbroni M; Wildgruber M; Salvermoser L; Corradini S; Schinner R; Ben Khaled N; Rössler D; Galun E; Goldberg SN; Ricke J; Kazmierczak PM
Radiat Oncol; 2023 Jul; 18(1):125. PubMed ID: 37507808
[TBL] [Abstract][Full Text] [Related]
18. Interstitial Brachytherapy for Limited (<4 cm) and Large (≥4 cm) Hepatic Metastases from Rare and Less Common Cancers.
Heinze C; Omari J; Damm R; Hass P; Brunner T; Surov A; Seidesticker R; Seidensticker M; Ricke J; Powerski M; Pech M
Anticancer Res; 2020 Aug; 40(8):4281-4289. PubMed ID: 32727755
[TBL] [Abstract][Full Text] [Related]
19. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique.
Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Hänninen EL; Felix R
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1496-505. PubMed ID: 15050329
[TBL] [Abstract][Full Text] [Related]
20. Interstitial Brachytherapy for Hepatocellular Carcinoma: Analysis of Prognostic Factors for Overall Survival and Progression-Free Survival and Application of a Risk Stratification Model.
Thormann M; Heitmann F; Wrobel V; Heinze C; March C; Hass P; Damm R; Surov A; Pech M; Omari J
Dig Dis; 2023; 41(6):957-966. PubMed ID: 37385234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
